​

Tonix Pharmaceuticals Ownership | Who Owns Tonix Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

Tonix Pharmaceuticals Ownership Summary

Tonix Pharmaceuticals is owned by 0.17% institutional investors, 0.06% insiders, and 99.78% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.19% of its assets in Tonix Pharmaceuticals shares.

TNXP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTonix Pharmaceuticals0.17%0.06%99.78%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-96.97%10,000-99.93%-0.40%1-96.15%--100.00%
Dec 31, 20243383.33%14,675,7791331.33%623808.00%26100.00%4300.00%
Sep 30, 202418-14.29%1,025,324242.52%-3072.85%13-38.10%1-
Jun 30, 202421-299,346---21---
Jun 30, 20231-97.22%7-100.00%----100.00%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr88.86K1.19%-
Fidelity Extended Market Index31.04K0.48%20.81K
Extended Equity Market Fund K12.98K0.20%8.92K
Fidelity Total Market Index10.50K0.16%6.48K
Fidelity Series Total Market Index7.85K0.12%5.30K
NT Ext Equity Mkt Idx Fd - L6.63K0.10%4.50K
Northern Trust Extended Eq Market Idx6.63K0.10%4.50K
NT Ext Equity Mkt Idx Fd - NL6.34K0.10%3.67K
Spartan Extended Market Index Pool E6.00K0.09%4.21K
Spartan Extended Market Index Pool F6.00K0.09%4.21K

Recent Insider Transactions

DateNameRoleActivityValue
May 15, 2025LEDERMAN SETH Chief Executive OfficerBuy$86.20K
Jun 29, 2022LEDERMAN SETH Chief Executive OfficerBuy$34.20K
Mar 25, 2022LEDERMAN SETH Chief Executive OfficerBuy$24.50K
Sep 28, 2021LEDERMAN SETH Chief Executive OfficerBuy$7.32K
May 25, 2021Goodman Daniel Wintner-Buy$5.60K

Insider Transactions Trends

DateBuySell
2025 Q21-
2025 Q1--
2024 Q2--
2024 Q1--
2023 Q2--

TNXP Ownership FAQ

Who Owns Tonix Pharmaceuticals?

Tonix Pharmaceuticals shareholders are primarily institutional investors at 0.17%, followed by 0.06% insiders and 99.77% retail investors. The average institutional ownership in Tonix Pharmaceuticals's industry, Biotech Stocks , is 63.97%, which Tonix Pharmaceuticals falls below.

Does Blackrock own Tonix Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Tonix Pharmaceuticals.

Who is the top mutual fund holder of Tonix Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Tonix Pharmaceuticals shares, with 1.19% of its total shares outstanding invested in 88.86K Tonix Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools